ASCO Direct LatAm Summit

MEXICO CITY, SEPTEMBER 3 - 5, 2024

About this Summit

The ASCO Direct™ LatAm Summit is planned to be a yearly Latin American Scientific Summit in specific oncology areas of interest (adapting every year according to that moment’s educational needs), licensed by the American Society of Clinical Oncology (ASCO®), one of the largest and most respected Medical Societies in the world, and leader in the field of Oncology.

This first Summit will take place in Mexico City, in the subsequent years will be hosted in other Latin American cities, and this first Summit will have the Mexican Society of Clinical Oncology as Scientific Partner

2024 topics: covering most recent scientific advances by the American Society of Clinical Oncology (ASCO), in the following areas:
- Breast cancer
- Lung cancer
- Gastrointestinal cancer

Why should you attend?

All lectures in this Summit will be presented by the original international speakers from ASCO official conferences.

Live streaming (and on demand) to all Latin American countries

Audio in Spanish, English and Portuguese.

national-cancer-institute-jeT_DE3esSI-unsplash_edited.jpg

Scientific Agenda

Scientific agenda:
- Lectures lineup will be determined by an ASCO approved Scientific Committee

Round tables in each cluster:
- ASCO speakers and LatAm experts appointed & coordinated by SMEO will discuss the scientific content and its impact in LatAm reality

Scientific Committee

Chairman

Pere Gascón, MD

Co-Director, Molecular and Translational Oncology Lab
Universitat de Barcelona

Jaffer Ajani, MD

Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center.
GI Scientific Committee

Scott Kopetz, MD

Deputy Chair for Translational Research, Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center.
GI Scientific Committee

Josep Tabernero, MD

Director, Vall d´Hebron Institute of Oncology, Universitat Autònoma de Barcelona.
GI Scientific Committee

Enriqueta Felip, MD

Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona
Lung Scientific Committee

Suresh Ramalingam, MD

Executive Director of Winship Cancer Institute of Emory University and Associate Vice President for cancer of Woodruff Health Sciences Center.
Lung Scientific Committee

Heather Wakelee, MD

Professor of Medicine and Chief of the Division of Oncology at Stanford University. Lung Scientific Committee

Javier Cortés, MD

Medical Scientific Director, IOB Institute of Oncology Madrid.
Breast Scientific Committee

Hope Rugo, MD

Director of the Breast Oncology Clinical Trials program, University of California at San Francisco.
Breast Scientific Committee

Erica Mayer, MD

Director, Breast Oncology Clinical Research, Dana-Farber Cancer Institute. Associate Professor, Harvard Medical School. Breast Scientific Committee

SMEO LatAm Experts Coordinating Committee

Sinuhé Barroso, MD

President, Mexican Society of Oncology

Yanin Chávarri, MD

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán.
ASCO Liaison for Latin America

Paula Cabrera, MD

National Institute of Cancerology
Vice President, Mexican Society of Oncology

Enrique Bargalló, MD

Director, Breast Cancer Center
National Institute of Cancerology

Snapinsta.app_315237294_5638609602899624_3543964005028004085_n_1080.jpg

Where & when

September 3-5, 2024
WTC Mexico City: Live event
Live Streaming: all Latin American countries

Sept. 3: registration, pre symposium
Sept. 4: scientific sessions all day
Sept. 5: scientific sessions in the morning, adjournment afternoon

Admission pricing

USD$250.00: ASCO or SMEO members
USD$275.00: Non-ASCO or non-SMEO Oncologist
USD$200.00: Nurse, resident, Allied Health, other general Professionals

ASCO Direct LatAm Summit 2024 Agenda

September 3, 2024:
- 09:00 - 13:00 h: Registration
- 15:00 - 19:00 h: Scientific Sessions
- 19:00 h: End of ASCO Direct LatAm Summit activities
September 4, 2024:
- 09:00 - 13:00 h: Scientific Sessions
- 15:00 - 19:00 h: Scientific Sessions
- 19:00 h: End of ASCO Direct LatAm Summit activities
September 5, 2024:
- 09:00 - 13:00 h: Scientific Sessions
- 13:00: Adjournment

Get in Touch

info-oncolatamsummit@global-minds.org

Join our social networks:

ASCO DIRECT™ programs are officially licensed by the American Society of Clinical Oncology, Inc. (ASCO). Each presentation is provided solely for educational and informational purposes and personal use only. No part of any presentation may be edited or altered, or reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, nor may it be used for commercial purposes, without in each case the express written permission of ASCO. The ideas and opinions expressed in this presentation do not necessarily reflect those of ASCO. The mention of any company, product, service, or therapy does not constitute an endorsement of any kind by ASCO. It is the responsibility of the treating physician or other health care provider, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient. Viewers are advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify , among other matters, the dosage, the method and duration of administration, or contraindications. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in this presentation or any errors or omissions.